Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $3.3 million.

  • Mirum Pharmaceuticals' Interest & Investment Income fell 628.42% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year decrease of 1289.42%. This contributed to the annual value of $13.8 million for FY2024, which is 41.5% up from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Interest & Investment Income stood at $3.3 million for Q3 2025, which was down 628.42% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, Mirum Pharmaceuticals' Interest & Investment Income peaked at $4.1 million during Q3 2023, and registered a low of $65000.0 during Q4 2021.
  • In the last 5 years, Mirum Pharmaceuticals' Interest & Investment Income had a median value of $3.0 million in 2025 and averaged $2.2 million.
  • Per our database at Business Quant, Mirum Pharmaceuticals' Interest & Investment Income tumbled by 8024.69% in 2021 and then surged by 319692.31% in 2022.
  • Mirum Pharmaceuticals' Interest & Investment Income (Quarter) stood at $65000.0 in 2021, then skyrocketed by 3196.92% to $2.1 million in 2022, then surged by 76.15% to $3.8 million in 2023, then fell by 15.13% to $3.2 million in 2024, then rose by 1.47% to $3.3 million in 2025.
  • Its Interest & Investment Income stands at $3.3 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.0 million for Q1 2025.